André Engling
7Patents
3h-index
19Co-inventors
46Inventor score
Filing activity: May 5, 2010 → Jan 7, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10117932B2 | Uses of immunoconjugates targeting CD138 | Human Necessities | 7 | Active |
| US9289509B2 | Uses of immunoconjugates targeting CD138 | Performing Operations; Transporting | 6 | Active |
| US8956607B2 | Humanized anti-IL 10 antibodies for the treatment of systemic lupus erythematosus (SLE) | Chemistry; Metallurgy | 4 | Active |
| US8852871B2 | Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE) | Chemistry; Metallurgy | 2 | Active |
| US9995733B2 | Agents for treating disease | Physics | 0 | Active |
| US9605066B2 | Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE) | Chemistry; Metallurgy | 0 | Active |
| US9540436B2 | Use of antibodies for detection of IL-10 | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.